Chiron Recovery Implements Medically Assisted Treatment (MAT) Program to Treat Opioid Addiction

Press Release ( - PALM BEACH GARDENS, Fla. - Feb 22, 2018 - Chiron Recovery, an evidenced-based dual diagnosis treatment facility, recently implemented a MAT program for the treatment of opioid addiction. At Chiron Recovery, we believe that relying solely on an abstinence-based program incorrectly insinuates that addiction is a failure of willpower or morals and only further stigmatizes addiction and its treatment. Addiction is a chronic disease and just like other chronic diseases, we are confident that successful treatment exists in a combination of medication merged with the current psychosocial services including therapy and 12 step programs. We strongly believe based on numerous evidence-based studies that Medically Assisted Treatment (MAT) is a necessary component of treatment for our current opioid epidemic. We are not alone in this belief as the federal government and some of the largest public health organizations in the United States including the Centers for Disease Control and Prevention (CDC), the National Institute on Drug Abuse (NIDA), and the World Health Organization (WHO) also support and recommend MAT.

We utilize buprenorphine combined with naloxone due to its accessibility, low risk for misuse, abuse, and overdose, and success rates when compared to traditional treatment or other approved MAT options including methadone and naltrexone.

For further information about this program please visit our website at or call 888-403-7062 to speak with a clinical specialist about a treatment program.

Source : Chiron Recovery
Business Info :
Chiron Recovery

You may also like this  

CATEGORIES : Healthcare


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.